Status:
COMPLETED
The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
American Diabetes Association
Sanofi
Conditions:
Diabetes Mellitus, Type 2
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A 4 week prospective, randomized controlled study was carried out to assess the impact of a care delivery intervention which focused on blood glucose (BG) management among adults with type 2 diabetes ...
Detailed Description
We evaluated a concise diabetes care delivery intervention designed to advance glycemic medications and deliver diabetes self-management education (DSME) among adults with type 2 diabetes presenting t...
Eligibility Criteria
Inclusion
- A new or existing diagnosis of type 2 diabetes;
- BG \> 200 mg/dl in the ED;
- age \>/= 18 years;
- willing and able to check BG and self-inject insulin, if required and otherwise stable for discharge to the outpatient setting.
Exclusion
- type 1 diabetes and other specific types of diabetes per the American Diabetes Association Position Statement on the Classification of Diabetes Mellitus,
- pregnancy or anticipated conception in the next 3 months;
- treatment with a glucocorticoid, unless at a stable physiologic replacement dose; or
- a history of diabetic ketoacidosis.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT02269098
Start Date
February 1 2012
End Date
December 1 2013
Last Update
January 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010